Evaxion to present three-year EVX-01 melanoma trial data at ESMO

Markets Investing.com By Investing.com 17 Jul 2026 11:20 1 min read

Evaxion to present three-year EVX-01 melanoma trial data at ESMO

Evaxion to present three-year EVX-01 melanoma trial data at ESMO

Evaxion to present three-year EVX-01 melanoma trial data at ESMO

Read the full story on Investing.com → Opens the original article on www.investing.com

Summary aggregated from Investing.com's public RSS feed. The full reporting belongs to Investing.com — please read it on their site.